The American Diabetes Association (ADA) prevented the publication of opinion articles, leading authors to release them as preprints. The controversy centers around ADA’s control over published viewpoints.
The source, ars_technica_science, reports that the American Diabetes Association blocked publication of op-ed articles submitted for consideration. In response, the authors bypassed the traditional publishing route and posted their work as a preprint – a version of a scientific paper shared publicly before peer review.
Details surrounding *why* the ADA took this action are not fully explained in the source material, but it clearly demonstrates a disagreement over what viewpoints are allowed to be associated with the organization. The move raises questions about editorial control and freedom of expression within the field of diabetes research and advocacy. No further information was provided regarding the content of the blocked op-eds or the authors involved.
We don't rate truth. We strip the spin and show you which perspectives covered the story. You decide.
Read the original coverage
💬 Comments
📜 Comment Policy